These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1653630)

  • 1. Characterization of topoisomerase I and II activities in nuclear extracts during callogenesis in immature embryos of Zea mays.
    Carballo M; Giné R; Santos M; Puigdomènech P
    Plant Mol Biol; 1991 Jan; 16(1):59-70. PubMed ID: 1653630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
    Andrea JE; Adachi K; Morgan AR
    Mol Pharmacol; 1991 Oct; 40(4):495-501. PubMed ID: 1656189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA.
    Lin JH; Castora FJ
    Arch Biochem Biophys; 1995 Dec; 324(2):293-9. PubMed ID: 8554321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ATP requirement for activity of and complex formation by DNA topoisomerase II from human leukemic CCRF-CEM cells selected for resistance to teniposide.
    Danks MK; Schmidt CA; Deneka DA; Beck WT
    Cancer Commun; 1989; 1(2):101-9. PubMed ID: 2561733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A defect in DNA topoisomerase II activity in ataxia-telangiectasia cells.
    Mohamed R; Pal Singh S; Kumar S; Lavin MF
    Biochem Biophys Res Commun; 1987 Nov; 149(1):233-8. PubMed ID: 2825700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.
    Levac P; Moss T
    Chromosoma; 1996 Oct; 105(4):250-60. PubMed ID: 8854885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topoisomerase I and II cleavage of adenovirus DNA in vivo: both topoisomerase activities appear to be required for adenovirus DNA replication.
    Schaack J; Schedl P; Shenk T
    J Virol; 1990 Jan; 64(1):78-85. PubMed ID: 2152835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a potent catenation activity of HeLa cell nuclei.
    Holden JA; Low RL
    J Biol Chem; 1985 Nov; 260(27):14491-7. PubMed ID: 2997211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative adaptation of the bacteriophage P4 DNA unknotting assay for use in the biochemical and pharmacological characterization of topoisomerase II.
    Hofmann GA; Mirabelli CK; Drake FH
    Anticancer Drug Des; 1990 Aug; 5(3):273-82. PubMed ID: 2169250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Requirement of DNA topoisomerases for in vitro chromatin assembly by 3T6 mouse cell extracts.
    Cáceres JF; Blangy D; Glikin GC
    Eur J Biochem; 1989 May; 181(2):531-7. PubMed ID: 2540977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone.
    Drake FH; Hofmann GA; Mong SM; Bartus JO; Hertzberg RP; Johnson RK; Mattern MR; Mirabelli CK
    Cancer Res; 1989 May; 49(10):2578-83. PubMed ID: 2540903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II DNA topoisomerases: enzymes that can unknot a topologically knotted DNA molecule via a reversible double-strand break.
    Liu LF; Liu CC; Alberts BM
    Cell; 1980 Mar; 19(3):697-707. PubMed ID: 6244895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knotting of the circular duplex DNA by type II DNA topoisomerase from Drosophila melanogaster.
    Hsieh T
    J Biol Chem; 1983 Jul; 258(13):8413-20. PubMed ID: 6305983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
    Lanza A; Tornaletti S; Stefanini M; Evans HH; Ricanati M; Astaldi Ricotti GC; Pedrini AM
    Carcinogenesis; 1993 Sep; 14(9):1759-63. PubMed ID: 8403196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant DNA topoisomerase II activity, radioresistance and inherited susceptibility to cancer.
    Cunningham JM; Francis GE; Holland MJ; Pirollo KF; Chang EH
    Br J Cancer; 1991 Jan; 63(1):29-36. PubMed ID: 1846552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase II, not topoisomerase I, is the proficient relaxase of nucleosomal DNA.
    Salceda J; Fernández X; Roca J
    EMBO J; 2006 Jun; 25(11):2575-83. PubMed ID: 16710299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of topoisomerase poisoning by antitumor drugs VM 26, fostriecin and camptothecin on DNA repair replication by mammalian cell extracts.
    Frosina G; Rossi O
    Carcinogenesis; 1992 Aug; 13(8):1371-7. PubMed ID: 1323426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of topoisomerase I and II cleavage sites on the Drosophila actin and Hsp70 heat shock genes.
    Kroeger PE; Rowe TC
    Biochemistry; 1992 Mar; 31(9):2492-501. PubMed ID: 1312349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic effects of inhibition of topoisomerase I or II activities in the CHO mutant EM9 and its parental line AA8.
    Cortés F; Piñero J; Palitti F
    Mutat Res; 1993 Aug; 288(2):281-9. PubMed ID: 7688089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered topoisomerase I activity and recombination activating gene expression in a human leukemia cell line resistant to doxorubicin.
    Riou JF; Grondard L; Petitgenet O; Abitbol M; Lavelle F
    Biochem Pharmacol; 1993 Sep; 46(5):851-61. PubMed ID: 8396937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.